{"id":418077,"date":"2021-01-20T16:08:29","date_gmt":"2021-01-20T21:08:29","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=418077"},"modified":"2021-01-20T16:08:29","modified_gmt":"2021-01-20T21:08:29","slug":"qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\/","title":{"rendered":"QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests <\/b><b>in the Face of Mutations of the Coronavirus<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><i>QIAstat-Dx and NeuMoDx tests continue to detect all known viral variants extremely effectively<\/i><\/li>\n<li><i>QIAGEN started cross-checking variants in May 2020 and continues to conduct biweekly assessments <\/i><\/li>\n<li><i>QIAseq SARS-CoV-2 Primer Panel helps with sequencing RNA and identifying mutations <\/i><\/li>\n<\/ul>\n<p>GERMANTOWN, Md. &amp; HILDEN, Germany&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nQIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its polymerase chain reaction (PCR) tests remain accurate and effective in detecting SARS-CoV-2 infections \u2013 and will continue to closely monitor their performance as global concerns mount regarding the detection of new viral variants by established testing methods.\n<\/p>\n<p>\nQIAGEN has successfully assessed its SARS-CoV-2 PCR tests against genetic mutations of the virus uploaded to the GISAID and GenBank public databases since May 2020. A latest round of assessments conducted in January 2021 again confirmed that no recorded mutations affected the sensitivity of QIAGEN assays for detection of SARS-CoV-2. Surveillance of genetic variations will continue on a biweekly basis.\n<\/p>\n<p>\n\u201cWe are pleased to report the known viral variants have had no impact on the effectiveness of our three SARS-CoV-2 PCR tests \u2013 PCR remains the gold standard for detecting RNA viruses like SARS-CoV-2,\u201d said Davide Manissero, M.D., Chief Medical Officer &#8211; Infection and Immune Diagnostics at QIAGEN. \u201cFurther genomic sequencing of SARS-CoV-2 samples worldwide will vastly increase transparency and help us identify and respond to potentially dangerous mutations of the virus, while at the same time broadening the database we can use to verify if vaccines and tests continue to be effective.\u201d\n<\/p>\n<p>\nVariants with potentially increased transmissibility include VUI 202012\/01 (first detected in the United Kingdom), 501Y.V2 (identified in South Africa), and B.1.1.28 P1 (most recently discovered in Brazil). As a virus encoded by RNA nucleotides, SARS-CoV-2 frequently mutates due to erroneous or ineffective replication of the virus genome. These mutations can sometimes produce viruses with altered properties or even entirely new strains.\n<\/p>\n<p>\nPlease find the full press release <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcorporate.qiagen.com%2Fnewsroom%2Fpress-releases%2F2021%2F20210120_SARS_COV_Mutations&amp;esheet=52364965&amp;newsitemid=20210120005691&amp;lan=en-US&amp;anchor=here&amp;index=1&amp;md5=711f620dec8fbbcfcd85f8a5fdc1506d\">here<\/a><\/p>\n<p>\nAdditional Information regarding QIAGEN\u2019s efforts against SARS-CoV-2 can be found <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.qiagen.com%2Fde%2Fapplications%2Finfectious-disease%2Fcoronavirus&amp;esheet=52364965&amp;newsitemid=20210120005691&amp;lan=en-US&amp;anchor=here&amp;index=2&amp;md5=54a1cf73d433f2a1a8af44508b52c5b8\">here<\/a><i \/><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210120005691r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210120005691\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210120005691\/en\/<\/a><\/span><\/p>\n<p><b>QIAGEN<br \/>\n<\/b><\/p>\n<p><b>Investor Relations<br \/>\n<\/b><br \/>John Gilardi +49 2103 29 11711<br \/>\n<br \/>Phoebe Loh +49 2103 29 11457<br \/>\n<br \/>e-mail: <a rel=\"nofollow\" href=\"mailto:ir@QIAGEN.com\">ir@QIAGEN.com<br \/>\n<\/a><\/p>\n<p><b>Public Relations<br \/>\n<\/b><br \/>Thomas Theuringer +49 2103 29 11826<br \/>\n<br \/>Robert Reitze +49 2103 29 11676<br \/>\n<br \/>e-mail: <a rel=\"nofollow\" href=\"mailto:pr@QIAGEN.com\">pr@QIAGEN.com <\/a><\/p>\n<p><b>KEYWORDS:<\/b> Germany Europe United States North America Maryland<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health Infectious Diseases Genetics Research Science Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus QIAstat-Dx and NeuMoDx tests continue to detect all known viral variants extremely effectively QIAGEN started cross-checking variants in May 2020 and continues to conduct biweekly assessments QIAseq SARS-CoV-2 Primer Panel helps with sequencing RNA and identifying mutations GERMANTOWN, Md. &amp; HILDEN, Germany&#8211;(BUSINESS WIRE)&#8211; QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its polymerase chain reaction (PCR) tests remain accurate and effective in detecting SARS-CoV-2 infections \u2013 and will continue to closely monitor their performance as global concerns mount regarding the detection of new viral variants by established testing methods. QIAGEN has successfully assessed its SARS-CoV-2 PCR tests against genetic mutations of the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-418077","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus QIAstat-Dx and NeuMoDx tests continue to detect all known viral variants extremely effectively QIAGEN started cross-checking variants in May 2020 and continues to conduct biweekly assessments QIAseq SARS-CoV-2 Primer Panel helps with sequencing RNA and identifying mutations GERMANTOWN, Md. &amp; HILDEN, Germany&#8211;(BUSINESS WIRE)&#8211; QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its polymerase chain reaction (PCR) tests remain accurate and effective in detecting SARS-CoV-2 infections \u2013 and will continue to closely monitor their performance as global concerns mount regarding the detection of new viral variants by established testing methods. QIAGEN has successfully assessed its SARS-CoV-2 PCR tests against genetic mutations of the &hellip; Continue reading &quot;QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-20T21:08:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210120005691r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus\",\"datePublished\":\"2021-01-20T21:08:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\\\/\"},\"wordCount\":407,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210120005691r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\\\/\",\"name\":\"QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210120005691r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-01-20T21:08:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210120005691r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210120005691r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\/","og_locale":"en_US","og_type":"article","og_title":"QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus - Market Newsdesk","og_description":"QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus QIAstat-Dx and NeuMoDx tests continue to detect all known viral variants extremely effectively QIAGEN started cross-checking variants in May 2020 and continues to conduct biweekly assessments QIAseq SARS-CoV-2 Primer Panel helps with sequencing RNA and identifying mutations GERMANTOWN, Md. &amp; HILDEN, Germany&#8211;(BUSINESS WIRE)&#8211; QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its polymerase chain reaction (PCR) tests remain accurate and effective in detecting SARS-CoV-2 infections \u2013 and will continue to closely monitor their performance as global concerns mount regarding the detection of new viral variants by established testing methods. QIAGEN has successfully assessed its SARS-CoV-2 PCR tests against genetic mutations of the &hellip; Continue reading \"QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-20T21:08:29+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210120005691r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus","datePublished":"2021-01-20T21:08:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\/"},"wordCount":407,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210120005691r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\/","name":"QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210120005691r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-01-20T21:08:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210120005691r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210120005691r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/qiagen-confirms-effectiveness-of-its-sars-cov-2-pcr-tests-in-the-face-of-mutations-of-the-coronavirus\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/418077","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=418077"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/418077\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=418077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=418077"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=418077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}